Zebra Technologies stock gains after Needham raises price target on strong Q2 2026 results

Zebra Technologies stock (ISIN US9892071054) is trading higher after Needham reiterated a Buy rating and raised its price target to USD 435 on September 17, 2026, pointing to record Q2 2026 results and strong demand for AI-enabled automation solutions.

Needham’s price target hike and Q2 2026 performance

According to Perplexity Finance, Needham reiterated its Buy rating on Zebra Technologies and lifted its price target to USD 435 following the company’s record Q2 2026 earnings release reported on August 4, 2026.

The same source reports that Zebra delivered record Q2 2026 results, including net sales growth of 20.4 percent compared with the prior-year quarter, alongside record margins and a raised full-year outlook, underscoring the company’s operational momentum and profitability in its core hardware and software businesses.

Perplexity Finance also notes that Needham’s higher price target implies roughly 24 percent upside from recent trading levels, signaling confidence that Zebra’s AI-driven automation portfolio and execution on mergers and acquisitions can sustain growth beyond the near term.

KC401 kiosk launch and healthcare deployment deepen automation story

Beyond the earnings and rating catalyst, Zebra has been expanding its product and solution footprint in automation. As Simply Wall St reports, the company recently introduced the KC401 self-service kiosk, a 10 inch, IP65-sealed device designed to handle routine inquiries across retail, hospitality, manufacturing, and healthcare environments.

Simply Wall St explains that the KC401 integrates with Zebra DNA software and existing CC6000 infrastructure and is intended to free the equivalent capacity of about four store associates per retail location for higher-value tasks, such as merchandising and in-store customer assistance, highlighting the potential productivity gains for clients.

The same article notes that a recent rollout with University Health has put Zebra’s mobile computers and printers deeper into inpatient workflows, indicating that hospitals are willing to embed Zebra devices into mission-critical routines where downtime quickly becomes a patient care issue, reinforcing the company’s positioning in healthcare automation.

Stock reaction and valuation backdrop

Perplexity Finance indicates that Zebra Technologies shares have been extending recent gains, with the stock trading at around USD 345.70 in intraday trading on September 17, 2026, up approximately 1.32 percent on the day, as investor enthusiasm around its AI-driven automation portfolio continues to build.

According to the same overview on Perplexity Finance, the shares had previously risen 2.16 percent to USD 351.11 in a recent session, rebounding from a 2.79 percent pullback, as investors digested the robust Q2 2026 results and the raised full-year guidance, showing that the market has been volatile but broadly constructive since the earnings beat.

Simply Wall St points out that Zebra’s long-term narrative currently projects revenue of about USD 7.2 billion and earnings of roughly USD 991.3 million by 2029, assuming annual revenue growth of around 7.0 percent from current earnings of approximately USD 539.0 million, which frames Needham’s upside view against a multi-year growth trajectory.

Closing price and market metrics

Per MarketBeat’s insider trading overview for Zebra Technologies, the stock closed at USD 347.81 on Nasdaq on September 17, 2026, a gain of 1.94 percent versus the prior close, with an after-hours indication of USD 347.94 shortly after 4:01 p.m. Eastern Time, underscoring that the price target hike and strong Q2 2026 data have been reflected in a firmer share price.

More news and analyses on Zebra Technologies stock